Revenue
259 million USD
2026 Q2 · USD
Exact inputs and evidence
- Revenue: 259283000 USD Source
Fundies. English
MEDICAL PROPERTIES TRUST INC
EDGARAnnual consolidated revenue for 2025: about USD 972M, using the latest reported figures. The previous period, 2024, was about USD 995.5M.
Latest quarter
- Cash and cash equivalents
- 397 million USD Source
Exact value
396558000 USD
- Long-term debt including current maturities
- 9.7 billion USD Source
Exact value
9704996000 USD
- Shares outstanding
- 597 million shares Source
Exact value
596786000 shares
Reported share-count change
-0.67% · -4.03 million shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
Trailing twelve months
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
Revenue
1.02 billion USD
2025-07-01 – 2026-06-30
Exact inputs and evidence
Net income
-30.2 million USD
2025-07-01 – 2026-06-30
Exact inputs and evidence
Operating cash flow
227 million USD
2025-07-01 – 2026-06-30
Exact inputs and evidence
- Operating cash flow: 70703000 USD · 2025-01-01 – 2025-09-30 Source
- Operating cash flow: 52131000 USD · 2025-01-01 – 2025-06-30 Source
- Operating cash flow: 230767000 USD · 2025-01-01 – 2025-12-31 Source
- Operating cash flow: 70703000 USD · 2025-01-01 – 2025-09-30 Source
- Operating cash flow: -14259000 USD · 2026-01-01 – 2026-03-31 Source
- Operating cash flow: 48185000 USD · 2026-01-01 – 2026-06-30 Source
- Operating cash flow: -14259000 USD · 2026-01-01 – 2026-03-31 Source
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2026-10-29.
Financial data available through: 2025-12-31.
Coverage by financial measure
- Revenue: 11 of 11 periods available· newest 2025-12-31
- Operating income: 3 of 11 periods available· newest 2017-12-31
- Net income: 11 of 11 periods available· newest 2025-12-31
- Operating cash flow: 11 of 11 periods available· newest 2025-12-31
- capital expenditure: No compatible figures in this window
- Total assets: 11 of 11 periods available· newest 2025-12-31
- Total liabilities: 11 of 11 periods available· newest 2025-12-31
- current assets: No compatible figures in this window
- current liabilities: No compatible figures in this window
- Cash and cash equivalents: 11 of 11 periods available· newest 2025-12-31
- Long-term debt including current maturities: 11 of 11 periods available· newest 2025-12-31
- Shares outstanding: 11 of 11 periods available· newest 2025-12-31
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
What changed year over year
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Revenue
-2.4%Prior period
USD 995.55 million
–
Current period
USD 972.02 million
–
Exact inputs and evidence
972022000 − 995547000 = -23525000 USD
995547000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source972022000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 2.13 billionPrior period
−USD 2.41 billion
–
Current period
−USD 277.05 million
–
Exact inputs and evidence
-277049000 − -2410271000 = 2133222000 USD
-2410271000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-277049000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
-6%Prior period
USD 245.48 million
–
Current period
USD 230.77 million
–
Exact inputs and evidence
230767000 − 245483000 = -14716000 USD
245483000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source230767000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Capital expenditure.
Where revenue goes
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
2025 2025-01-01 – 2025-12-31
- Revenue USD 972.02 million 100% of revenue
- Operating costs Derived Unavailable An input is unavailable.
- Operating income Unavailable An input is unavailable.
- Tax, interest and other Derived Unavailable An input is unavailable.
- Net income −USD 277.05 million −29% of revenue
Cash
- Operating cash flow USD 230.77 million 24% of revenue
- Capital expenditure Unavailable An input is unavailable.
- Free cash flow Derived Unavailable An input is unavailable.
Share of revenue by period
- Net income
- Tax, interest and other
- Operating costs
- 2016 42%22%37%
- 2017 41%28%31%
- 2018 Not shown: operating income or net income is not reported.
- 2019 Not shown: operating income or net income is not reported.
- 2020 Not shown: operating income or net income is not reported.
- 2021 Not shown: operating income or net income is not reported.
- 2022 Not shown: operating income or net income is not reported.
- 2023 Not shown: operating income or net income is not reported.
- 2024 Not shown: operating income or net income is not reported.
- 2025 Not shown: operating income or net income is not reported.
Values and sources
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2016 2016-01-01 – 2016-12-31 | 541137000 | 199499000 Derived | 341638000 | 116590000 Derived | 225048000 | Unavailable | Source
|
| 2017 2017-01-01 – 2017-12-31 | 704745000 | 219161000 Derived | 485584000 | 195791000 Derived | 289793000 | Unavailable | Source
|
| 2018 2018-01-01 – 2018-12-31 | 784522000 | Unavailable | Unavailable | Unavailable | 1016685000 | Unavailable | Source
|
| 2019 2019-01-01 – 2019-12-31 | 854197000 | Unavailable | Unavailable | Unavailable | 374684000 | Unavailable | Source
|
| 2020 2020-01-01 – 2020-12-31 | 1249238000 | Unavailable | Unavailable | Unavailable | 431450000 | Unavailable | Source
|
| 2021 2021-01-01 – 2021-12-31 | 1544669000 | Unavailable | Unavailable | Unavailable | 656021000 | Unavailable | Source
|
| 2022 2022-01-01 – 2022-12-31 | 1542851000 | Unavailable | Unavailable | Unavailable | 902597000 | Unavailable | Source
|
| 2023 2023-01-01 – 2023-12-31 | 871799000 | Unavailable | Unavailable | Unavailable | -556476000 | Unavailable | Source
|
| 2024 2024-01-01 – 2024-12-31 | 995547000 | Unavailable | Unavailable | Unavailable | -2410271000 | Unavailable | Source
|
| 2025 2025-01-01 – 2025-12-31 | 972022000 | Unavailable | Unavailable | Unavailable | -277049000 | Unavailable | Source
|
Amounts are exact, in USD.
Growth
Sales over time and how quickly they are changing.
Revenue
Revenue reported for each complete financial period.
USD 972M 2025
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2016 | Revenue | 541137000 |
|
| 2017 | Revenue | 704745000 |
|
| 2018 | Revenue | 784522000 |
|
| 2019 | Revenue | 854197000 |
|
| 2020 | Revenue | 1249238000 |
|
| 2021 | Revenue | 1544669000 |
|
| 2022 | Revenue | 1542851000 |
|
| 2023 | Revenue | 871799000 |
|
| 2024 | Revenue | 995547000 |
|
| 2025 | Revenue | 972022000 |
|
Revenue growth
Change in revenue from the same financial period one year earlier.
-2.4% 2025
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2016 | Year over year | 22.5% |
|
| 2017 | Year over year | 30.2% |
|
| 2018 | Year over year | 11.3% |
|
| 2019 | Year over year | 8.9% |
|
| 2020 | Year over year | 46.2% |
|
| 2021 | Year over year | 23.6% |
|
| 2022 | Year over year | -0.1% |
|
| 2023 | Year over year | -43.5% |
|
| 2024 | Year over year | 14.2% |
|
| 2025 | Year over year | -2.4% |
|
Profit and cash
How much revenue becomes profit, and how much cash operations generate.
Profit margins
Operating income, net income and free cash flow as a share of revenue.
Operating margin 68.9% 2017
Net margin -28.5% 2025
- Operating margin
- Net margin
- Free cash flow margin
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2016 | Operating margin | 63.1% |
|
| 2017 | Operating margin | 68.9% |
|
| 2018-12-31 | Operating margin | Not reported |
|
| 2019-12-31 | Operating margin | Not reported |
|
| 2020-12-31 | Operating margin | Not reported |
|
| 2021-12-31 | Operating margin | Not reported |
|
| 2022-12-31 | Operating margin | Not reported |
|
| 2023-12-31 | Operating margin | Not reported |
|
| 2024-12-31 | Operating margin | Not reported |
|
| 2025-12-31 | Operating margin | Not reported |
|
| 2016 | Net margin | 41.6% |
|
| 2017 | Net margin | 41.1% |
|
| 2018 | Net margin | 129.6% |
|
| 2019 | Net margin | 43.9% |
|
| 2020 | Net margin | 34.5% |
|
| 2021 | Net margin | 42.5% |
|
| 2022 | Net margin | 58.5% |
|
| 2023 | Net margin | -63.8% |
|
| 2024 | Net margin | -242.1% |
|
| 2025 | Net margin | -28.5% |
|
| 2016 | Free cash flow margin | Not reported |
|
| 2017 | Free cash flow margin | Not reported |
|
| 2018 | Free cash flow margin | Not reported |
|
| 2019 | Free cash flow margin | Not reported |
|
| 2020 | Free cash flow margin | Not reported |
|
| 2021 | Free cash flow margin | Not reported |
|
| 2022 | Free cash flow margin | Not reported |
|
| 2023 | Free cash flow margin | Not reported |
|
| 2024 | Free cash flow margin | Not reported |
|
| 2025 | Free cash flow margin | Not reported |
|
Operating cash flow
Cash generated by the company’s normal business operations.
USD 230.8M 2025
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2016 | Operating cash flow | 263838000 |
|
| 2017 | Operating cash flow | 362235000 |
|
| 2018 | Operating cash flow | 449088000 |
|
| 2019 | Operating cash flow | 494117000 |
|
| 2020 | Operating cash flow | 617636000 |
|
| 2021 | Operating cash flow | 811656000 |
|
| 2022 | Operating cash flow | 739010000 |
|
| 2023 | Operating cash flow | 505786000 |
|
| 2024 | Operating cash flow | 245483000 |
|
| 2025 | Operating cash flow | 230767000 |
|
Free cash flow
Operating cash flow minus capital expenditure for the same period and unit.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2016 | Free cash flow | Unavailable |
|
| 2017 | Free cash flow | Unavailable |
|
| 2018 | Free cash flow | Unavailable |
|
| 2019 | Free cash flow | Unavailable |
|
| 2020 | Free cash flow | Unavailable |
|
| 2021 | Free cash flow | Unavailable |
|
| 2022 | Free cash flow | Unavailable |
|
| 2023 | Free cash flow | Unavailable |
|
| 2024 | Free cash flow | Unavailable |
|
| 2025 | Free cash flow | Unavailable |
|
Balance sheet
Liabilities and short-term ability to meet obligations at each period end.
Liabilities to assets
Total liabilities as a share of total assets.
69.3% 2025
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2016 | Liabilities / assets | 49.3% |
|
| 2017 | Liabilities / assets | 57.5% |
|
| 2018 | Liabilities / assets | 48.4% |
|
| 2019 | Liabilities / assets | 51.4% |
|
| 2020 | Liabilities / assets | 56.4% |
|
| 2021 | Liabilities / assets | 58.8% |
|
| 2022 | Liabilities / assets | 56.3% |
|
| 2023 | Liabilities / assets | 58.3% |
|
| 2024 | Liabilities / assets | 66.2% |
|
| 2025 | Liabilities / assets | 69.3% |
|
Current assets to current liabilities
Current assets divided by current liabilities.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2016-12-31 | Current assets / current liabilities | Not reported | No source recorded |
| 2017-12-31 | Current assets / current liabilities | Not reported | No source recorded |
| 2018-12-31 | Current assets / current liabilities | Not reported | No source recorded |
| 2019-12-31 | Current assets / current liabilities | Not reported | No source recorded |
| 2020-12-31 | Current assets / current liabilities | Not reported | No source recorded |
| 2021-12-31 | Current assets / current liabilities | Not reported | No source recorded |
| 2022-12-31 | Current assets / current liabilities | Not reported | No source recorded |
| 2023-12-31 | Current assets / current liabilities | Not reported | No source recorded |
| 2024-12-31 | Current assets / current liabilities | Not reported | No source recorded |
| 2025-12-31 | Current assets / current liabilities | Not reported | No source recorded |
Cash generation
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2016 2016-01-01 – 2016-12-31 | USD 225.05 million Exact valueExact value: 225048000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 263.84 million Exact valueExact value: 263838000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2017 2017-01-01 – 2017-12-31 | USD 289.79 million Exact valueExact value: 289793000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 362.24 million Exact valueExact value: 362235000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2018 2018-01-01 – 2018-12-31 | USD 1.02 billion Exact valueExact value: 1016685000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 449.09 million Exact valueExact value: 449088000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2019 2019-01-01 – 2019-12-31 | USD 374.68 million Exact valueExact value: 374684000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 494.12 million Exact valueExact value: 494117000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2020 2020-01-01 – 2020-12-31 | USD 431.45 million Exact valueExact value: 431450000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 617.64 million Exact valueExact value: 617636000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2021 2021-01-01 – 2021-12-31 | USD 656.02 million Exact valueExact value: 656021000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 811.66 million Exact valueExact value: 811656000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2022 2022-01-01 – 2022-12-31 | USD 902.6 million Exact valueExact value: 902597000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 739.01 million Exact valueExact value: 739010000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2023 2023-01-01 – 2023-12-31 | −USD 556.48 million Exact valueExact value: -556476000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 505.79 million Exact valueExact value: 505786000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2024 2024-01-01 – 2024-12-31 | −USD 2.41 billion Exact valueExact value: -2410271000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 245.48 million Exact valueExact value: 245483000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2025 2025-01-01 – 2025-12-31 | −USD 277.05 million Exact valueExact value: -277049000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 230.77 million Exact valueExact value: 230767000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Dataset coverage and company identifiers
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
132 filings · 4,450 latest values · 4,450 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001287865, 1287865, MPT, MPW, edgar:1287865
Also known as MEDICAL PROPERTIES TRUST INC, MEDICAL PROPERTIES TRUST INC., MEDICAL PROPERTIES TRUST, INC., Medical Properties Trust, Inc, Medical Properties Trust, Inc.